Lucus Advisors’s Accendra Health ACH Stock Holding History

Lucus Advisors’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-11,953	Closed	-$414K	–	235
2017 Q1	$414K	Buy	+11,953	New	+$427K	0.38%	50

Other funds holding ACH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Lucus Advisors's ACH Position: Q2 2017 in Review

Lucus Advisors sold out of Accendra Health (ACH) in Q2 2017, closing a stake of 11,953 shares — an estimated $414K sold.

Lucus Advisors first reported a position in ACH in Q1 2017 and held it in 1 quarter. The position peaked at $414K in Q1 2017. 273 funds tracked by Wall St. Rank hold ACH as of Q2 2017.

Lucus Advisors reported no remaining Accendra Health position as of Q2 2017 after selling out during the quarter.
Lucus Advisors sold 11,953 Accendra Health shares in Q2 2017, an estimated $414K.
Lucus Advisors first reported a position in Accendra Health in Q1 2017 and held it in 1 quarter.
Lucus Advisors's Accendra Health position peaked at $414K in Q1 2017.
273 funds tracked by Wall St. Rank held Accendra Health as of Q2 2017.

Based on Lucus Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.